METASTATIC LUNG CANCER

Clinical trials for METASTATIC LUNG CANCER explained in plain language.

Never miss a new study

Get alerted when new METASTATIC LUNG CANCER trials appear

Sign up with your email to follow new studies for METASTATIC LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 9 Not yet recruiting 1 Not yet finished but already full! 3 Completed 3 Terminated 1

New drug cocktail aims to outsmart lung cancer resistance

Disease control Not yet recruiting

This study tests a new drug (ANS014004) combined with a standard targeted therapy (EGFR-TKI) in people with advanced EGFR-mutated non-small cell lung cancer. The goal is to find a safe dose and see if the combination can shrink tumors or stop them from growing, especially when th…

Matched conditions: METASTATIC LUNG CANCER

Phase: PHASE1, PHASE2 • Sponsor: Beijing Pearl Biotechnology Limited Liability Company • Aim: Disease control

Last updated May 17, 2026 00:50 UTC

METASTATIC LUNG CANCER

Get alerted when new METASTATIC LUNG CANCER trials appear

New drug cocktail aims to outsmart lung cancer resistance